These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34075714)

  • 21. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy study.
    Reeve BW; Ndlangalavu G; Mishra H; Palmer Z; Tshivhula H; Rockman L; Naidoo S; Mbu DL; Naidoo CC; Derendinger B; Walzl G; Malherbe ST; van Helden PD; Semitala FC; Yoon C; Gupta RK; Noursadeghi M; Warren RM; Theron G
    medRxiv; 2023 Jun; ():. PubMed ID: 37333303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a Urine-Based Rapid Molecular Diagnostic Test with Potential to Be Used at Point-of-Care for Pulmonary Tuberculosis: Cape Town Cohort.
    Patel K; Nagel M; Wesolowski M; Dees S; Rivera-Milla E; Geldmacher C; Dheda K; Hoelscher M; Labugger I
    J Mol Diagn; 2018 Mar; 20(2):215-224. PubMed ID: 29269279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response.
    Warsinske HC; Rao AM; Moreira FMF; Santos PCP; Liu AB; Scott M; Malherbe ST; Ronacher K; Walzl G; Winter J; Sweeney TE; Croda J; Andrews JR; Khatri P
    JAMA Netw Open; 2018 Oct; 1(6):e183779. PubMed ID: 30646264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis.
    van't Hoog AH; Cobelens F; Vassall A; van Kampen S; Dorman SE; Alland D; Ellner J
    PLoS One; 2013; 8(12):e82786. PubMed ID: 24367555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breath analysis as a potential diagnostic tool for tuberculosis.
    Kolk AH; van Berkel JJ; Claassens MM; Walters E; Kuijper S; Dallinga JW; van Schooten FJ
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):777-82. PubMed ID: 22507235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.
    Sigal GB; Pinter A; Lowary TL; Kawasaki M; Li A; Mathew A; Tsionsky M; Zheng RB; Plisova T; Shen K; Katsuragi K; Choudhary A; Honnen WJ; Nahid P; Denkinger CM; Broger T
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis.
    Dowdy DW; Steingart KR; Pai M
    PLoS Med; 2011 Aug; 8(8):e1001074. PubMed ID: 21857810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aptamer-Based TB Antigen Tests for the Rapid Diagnosis of Pulmonary Tuberculosis: Potential Utility in Screening for Tuberculosis.
    Lavania S; Das R; Dhiman A; Myneedu VP; Verma A; Singh N; Sharma TK; Tyagi JS
    ACS Infect Dis; 2018 Dec; 4(12):1718-1726. PubMed ID: 30350564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid diagnosis of TB using GC-MS and chemometrics.
    Dang NA; Janssen HG; Kolk AH
    Bioanalysis; 2013 Dec; 5(24):3079-97. PubMed ID: 24320132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Airborne Biomarkers for Point-of-Care Diagnostics.
    Fung AO; Mykhaylova N
    J Lab Autom; 2014 Jun; 19(3):225-47. PubMed ID: 24464813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosis.
    Younis H; Kerschbaumer I; Moon JY; Kim RS; Blanc CJ; Chen T; Wood R; Lawn S; Achkar JM
    PLoS One; 2019; 14(6):e0218606. PubMed ID: 31237915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress toward Developing Sensitive Non-Sputum-Based Tuberculosis Diagnostic Tests: the Promise of Urine Cell-Free DNA.
    MacLean E; Nathavitharana RR
    J Clin Microbiol; 2021 Jul; 59(8):e0070621. PubMed ID: 33980646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults.
    Calderwood CJ; Reeve BW; Mann T; Palmer Z; Nyawo G; Mishra H; Ndlangalavu G; Abubakar I; Noursadeghi M; Theron G; Gupta RK
    J Infect; 2023 Jan; 86(1):24-32. PubMed ID: 36375640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of lipoarabinomannan antigen in tuberculosis diagnostics: current evidence.
    Sarkar P; Biswas D; Sindhwani G; Rawat J; Kotwal A; Kakati B
    Postgrad Med J; 2014 Mar; 90(1061):155-63. PubMed ID: 24429376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing Tuberculosis: What Do New Technologies Allow Us to (Not) Do?
    Abdulgader SM; Okunola AO; Ndlangalavu G; Reeve BWP; Allwood BW; Koegelenberg CFN; Warren RM; Theron G
    Respiration; 2022; 101(9):797-813. PubMed ID: 35760050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment.
    Jacobs R; Tshehla E; Malherbe S; Kriel M; Loxton AG; Stanley K; van der Spuy G; Walzl G; Chegou NN
    Cytokine; 2016 May; 81():50-6. PubMed ID: 26878648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.
    Shah M; Variava E; Holmes CB; Coppin A; Golub JE; McCallum J; Wong M; Luke B; Martin DJ; Chaisson RE; Dorman SE; Martinson NA
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):145-51. PubMed ID: 19692904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium tuberculosis lipolytic enzymes as potential biomarkers for the diagnosis of active tuberculosis.
    Brust B; Lecoufle M; Tuaillon E; Dedieu L; Canaan S; Valverde V; Kremer L
    PLoS One; 2011; 6(9):e25078. PubMed ID: 21966416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.